Skip to main navigation Skip to search Skip to main content

Determination of the risk of myalgia in patients receiving concomitant simvastatin and gemfibrozil therapy

Research output: Other contribution

Original languageAmerican English
StatePublished - Jan 1 2006

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this